Orchid Pharma Limited (ORCHPHARMA) — share transfer

📢 Key Event
Confirmation certificate issued for Q4 FY2025-26 compliance

💡 Investor Takeaway
The confirmation validates regulatory compliance without impacting shareholding or financials.

Orchid Pharma Limited confirmed compliance with SEBI's Regulation 74(5) for Q4 FY2025-26 via its registrar, Abhipra Capital Limited, covering share transfer agent activities and regulatory adherence as of March 31, 2026.

📄 View Original Announcement (PDF)

📊 Stock Analysis — ORCHPHARMA ✨ Ask AI About This

About Orchid Pharma Limited (ORCHPHARMA)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹3,614.24 Cr P/E: 32.3

View full ORCHPHARMA stock details →

📡 Get AI alerts when ORCHPHARMA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ORCHPHARMA — Free

💡 Ask AI about this filing

"How does this affect ORCHPHARMA margins?" "Compare with last quarter results" "What should investors watch for?"

Ask AI Free →

📊 More ORCHPHARMA filings

See all ORCHPHARMA filings →

🔥 Also filed on 9 April 2026

PRESTIGE Prestige Estates Projects Limited Announcement SHRIRAMFIN Shriram Finance Limited Announcement SAATVIKGL Saatvik Green Energy Limited Announcement YESBANK Yes Bank Limited Financial Results SAATVIKGL Saatvik Green Energy Limited Announcement YESBANK Yes Bank Limited Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when ORCHPHARMA files new disclosures

Track ORCHPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track ORCHPHARMA — Free

Free account · 2 AI queries/day